1st Feb 2011 16:39
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in interests in respect of the under-mentioned Director and Person Discharging Managerial Responsibility:-
Dr P Vallance
| Following the vesting of 8,897.219 ordinary shares under the GlaxoSmithKline Deferred Investment Award on 29 January 2011, Dr P Vallance received a payment of £11.51 per ordinary share on 29 January 2011.
The Company was advised of this transaction on 1 February 2011.
|
This notifications are in accordance with Disclosure and Transparency Rule 3.1.4R(1)(b).
V A Whyte
Company Secretary
1 February 2011
Related Shares:
Glaxosmithkline